Bexion Pharmaceuticals
PrivateLast Round
Grant
Nov 14, 2024
Total Funding Raised
$42.36M
Company Overview
Bexion Pharmaceuticals operates in Healthcare & Life Sciences and is based in Covington, Kentucky. Its latest recorded funding round was a Grant round in November 2024.
Bexion Pharmaceuticals is a biotechnology company developing biologic therapies that target sphingolipid metabolism to treat solid tumors and chemotherapy-induced peripheral neuropathy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bexion Pharmaceuticals Comparables
Compare Bexion Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sapience Therapeutics | 80% | |
| Apogee Biotechnology Corporation | 80% | |
| Vigeo Therapeutics | 77% |
For institutional investors. Book with your work email.
Bexion Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 14, 2024 | ||||
| Series C | Feb 4, 2022 | ||||
| Debt | Feb 1, 2021 | ||||
| Debt | Apr 13, 2020 | ||||
| Series B | Apr 30, 2019 | ||||
Grant | Oct 13, 2013 |
For institutional investors. Book with your work email.
Bexion Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Keyhorse Capital | Series A |
| QCA Ventures | Series A |
| NIH RADx | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Kentucky Cabinet for Economic Development | Grant |
| Small Business Administration | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 45% MoM.
- Apr 16, 2026
Monthly visitors grew 181% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Bexion Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bexion Pharmaceuticals's valuation, stock price, and market status.
Is Bexion Pharmaceuticals a public or private company?
Bexion Pharmaceuticals is a private company.
What is the current stock price of Bexion Pharmaceuticals?
Bexion Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Bexion Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bexion Pharmaceuticals worth (valuation)?
Valuation information for Bexion Pharmaceuticals is not publicly available.
Can I buy Bexion Pharmaceuticals stock?
Bexion Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bexion Pharmaceuticals's last funding round?
Bexion Pharmaceuticals's most recent funding round was Grant on November 14, 2024.
Who are the main investors in Bexion Pharmaceuticals?
Key investors in Bexion Pharmaceuticals include National Cancer Institute, NIH RADx, The Michael J. Fox Foundation for Parkinson's Research, Kentucky Cabinet for Economic Development.
Will Bexion Pharmaceuticals IPO soon?
No public IPO plans have been announced for Bexion Pharmaceuticals.
How can I track Bexion Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Bexion Pharmaceuticals's shares on secondary markets.